Safety and Pharmacokinetic Profile of an Immunobiological Drug (anti SARS-Cov-2) in the Treatment of CoViD-19
G. A. Keller,G. D. Girolamo,H. E. D. Salvo,D. S. Zotta,R. Salvi,L. Madeo,E. R. Garcia,I. Colaianni,J. Bartolome,S. Miranda,G. Bramuglia,A. R. D. Roodt,G. Temprano,C. Bonel,J. C. Dokmetjian
